Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Cencita H. C. N. Pessoa"'
Autor:
Fernanda Vaisman, Denise Momesso, Daniel A. Bulzico, Cencita H. C. N. Pessoa, Manuel Domingos Gonçalves da Cruz, Fernando Dias, Rossana Corbo, Mario Vaisman, R. Michael Tuttle
Publikováno v:
Journal of Thyroid Research, Vol 2013 (2013)
Background and Objective. An individualized risk-based approach to the treatment of thyroid cancer is being extensively discussed in the recent literature. However, controversies about the ideal surgical approach remain an important issue with regard
Externí odkaz:
https://doaj.org/article/1746a068b7f748cf971dc6781bfa7301
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study
Autor:
Léa Maria Zanini Maciel, Carla Vaz Ferreira, Sergio P. A. Toledo, Flávia O. F. Valente, Luciana A. Castroneves, Rui M. B. Maciel, Gisah Amaral de Carvalho, Rita V Weiss, Janete M. Cerutti, Henrique de Campos Reis Galvão, Tânia M B L Ferraz, Célia Regina Nogueira, Patrícia Künzle Ribeiro Magalhães, Francisco M de Castro, Shana de Souto Weber, Vera L.G. Leal, Cencita H. C. N. Pessoa, M Inez C França, Natassia Elena Bufalo, Gláucia Maria Ferreira da Silva Mazeto, Maria A. Sousa, Ji H. Yang, Bibiana Prada, Débora Rodrigues Siqueira, M Cecília Martins-Costa, Magnus R. Dias-da-Silva, Rossana Corbo, João Roberto Maciel Martins, Ana Luiza Maia, Ana O. Hoff, Delmar M. Lourenço, Laura Sterian Ward, Edenir Inêz Palmero, Hans Graf, Marcio W Lauria, Rodrigo A. Toledo, Alexander A. L. Jorge, Ligia V. M. Assumpção, Anelise I Impellizzeri, Ilda S. Kunii, Fernanda Vaisman, Lucieli Ceolin, Fausto Germano-Neto, André Lopes Carvalho, Susan C. Lindsey, Cleber P. Camacho
Publikováno v:
Endocrine Connections
Endocrine Connections, Vol 8, Iss 3, Pp 289-298 (2019)
Endocrine Connections, Vol 8, Iss 3, Pp 289-298 (2019)
Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant genetic disease caused by RET gene germline mutations that is characterized by medullary thyroid carcinoma (MTC) associated with other endocrine tumors. Several reports have demonstr
Autor:
Leonardo Vieira Neto, Paulo Antônio Silvestre de Faria, Daniel Bulzico, Cencita H. C. N. Pessoa, Mario Vaisman, Marcela Pessoa de Paula, Bruno Vilhena, Fernanda Vaisman, Rossana Corbo
Publikováno v:
Cancer Research Frontiers. 2:368-379
Autor:
Daniel Bulzico, Mario Vaisman, Marcela Pessoa de Paula, Rossana Corbo, Maria Alice Neves Bordallo, Sima Ferman, Cencita H. C. N. Pessoa, Paulo Antônio Silvestre de Faria, Leonardo Vieira Neto
Publikováno v:
Pediatric Hematology and Oncology. 33:248-258
Prognostic markers that can help identifying precocious risk of unfavorable outcomes in patients with childhood adrenocortical tumors (ACTs) are still unclear. This observational and retrospective study aimed to identify clinical and pathology progno
Autor:
Daniel Bulzico, Douglas de Carvalho Leal, Fernanda Vaisman, Cencita H. C. N. Pessoa, Mario Vaisman, Michel Pontes Carneiro, Rossana Corbo, Flávia Paiva Proença Lobo Lopes, Daniel Barretto Kendler, Bruno Vilhena, Paulo Castro
Publikováno v:
Clinical Nuclear Medicine. 40:123-127
Medullary thyroid cancer (MTC) is a rare but potentially life-threatening disease with limited therapeutic options. As a neuroendocrine tumor, MTC expresses somatostatin receptors, and therefore, somatostatin-labeled radiopharmaceuticals could be use
Autor:
Ana Beatriz Santoro, Ronaldo R. S. Neves, Ricardo M. R. Meirelles, Daniel Bulzico, Guilherme Suarez-Kurtz, Daniela D. Vargens, Daniela Polessa Paula, Luiz Paulo Kowalski, Mateus de Camargo Barros Filho, Claudio J. Struchine, Cencita H. C. N. Pessoa
Publikováno v:
British Journal of Clinical Pharmacology. 78:1067-1075
Aim To evaluate the impact of genetic polymorphisms in uridine 5′-glucuronosylytansferases UGT1A1 and UGT1A3 and iodothyronine-deiodinases types 1 and 2 on levothyroxine (T4; 3,5,3′,5′-triiodo-L-thyronine) dose requirement for suppression of th
Autor:
Daniel Bulzico, Fernando Luiz Dias, R. Michael Tuttle, Fernanda Vaisman, Cencita H. C. N. Pessoa, Rossana Corbo, Mario Vaisman, Denise Momesso
Publikováno v:
Clinical Endocrinology. 77:132-138
SummaryObjective To validate the American Thyroid Association (ATA) initial risk of recurrence scheme and the Memorial Sloan Kettering Cancer Center (MSKCC) response to therapy re-stratification approach in a large cohort of patients with differentia
Autor:
Avelino Luz Machado, Daniel Bulzico, Maria Alice Neves Bordallo, Rossana Corbo, Cencita H. C. N. Pessoa, Luiz Antônio Magnata Filho, Andréia B. Soares, Fernando Luiz Dias, Sima Ferman
Publikováno v:
Arquivos Brasileiros de Endocrinologia & Metabologia v.54 n.7 2010
Arquivos Brasileiros de Endocrinologia & Metabologia
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Arquivos Brasileiros de Endocrinologia & Metabologia, Volume: 54, Issue: 7, Pages: 657-662, Published: OCT 2010
Arquivos Brasileiros de Endocrinologia & Metabologia
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Arquivos Brasileiros de Endocrinologia & Metabologia, Volume: 54, Issue: 7, Pages: 657-662, Published: OCT 2010
Spindle epithelial tumor with thymus-like element (SETTLE) is a rare malignant neoplasm of the thyroid, occurring predominantly in children, adolescents, and young adults. SETTLE usually presents itself as a thyroid mass, without metastases at diagno
Autor:
Flávia Paiva Proença Lobo Lopes, Rossana Corbo, Daniel Bulzico, Fern, Michel Pontes Carneiro, a Vaisman, Cencita H. C. N. Pessoa, Luiz de Souza Machado Neto
Publikováno v:
Journal of Nuclear Medicine & Radiation Therapy.
Medullary thyroid cancer is a rare tumor driven from neuroendocrine cells. In the last decade there has been important discoveries regarding its genetics and relationship between genotype and phenotype on familial cases. However remains unknown the b
Autor:
Carolina Martins do Prado, Elida B. Ojopi, Ronaldo R. S. Neves, Ricardo M. R. Meirelles, Vera L.G. Leal, Guilherme Suarez-Kurtz, Daniela D. Vargens, Pedro A. Gonçalves, Cencita H. C. N. Pessoa, Daniel Bulzico
Publikováno v:
Pharmacogenetics and genomics. 21(6)
There is a considerable interindividual variation in L-thyroxine [3,5,3',5'-tetraiodo-l-thyronine (T 4 )] dose required for thyrotropin (thyroid-stimulating hormone) suppression in patients with differentiated thyroid cancer. To investigate whether u